The effects of hypophysectomy and short-term GH replacement on insulin release and on some aspects of glucose metabolism in isolated rat islets of Langerhans were investigated. The effects on body, pancreas and adrenal gland weights, and on the levels of blood plasma constituents were also measured. Three to four weeks after hypophysectomy the early and late phases of insulin release from islets incubated with high concentrations of glucose, but not with low concentrations of glucose or with xylitol, leucine, arginine, tolbutamide, citrate or butyrate, were significantly lowered. Short-term GH replacement partially reversed the depression in glucose-stimulated insulin release. This reversal effect was not dependent on the increase in body weight of rats after GH replacement when the fall in adrenal gland but not in pancreas weight was also reversed. Nine out of the 12 plasma constituents measured, including glucose, were maintained in the control range of levels, but albumin, inorganic phosphate and urea nitrogen levels were altered after hypophysectomy or GH replacement.
(Received 16 July 1974) SUMMARY The effects of hypophysectomy and short-term GH replacement on insulin release and on some aspects of glucose metabolism in isolated rat islets of Langerhans were investigated. The effects on body, pancreas and adrenal gland weights, and on the levels of blood plasma constituents were also measured. Three to four weeks after hypophysectomy the early and late phases of insulin release from islets incubated with high concentrations of glucose, but not with low concentrations of glucose or with xylitol, leucine, arginine, tolbutamide, citrate or butyrate, were significantly lowered. Short-term GH replacement partially reversed the depression in glucose-stimulated insulin release. This reversal effect was not dependent on the increase in body weight of rats after GH replacement when the fall in adrenal gland but not in pancreas weight was also reversed. Nine out of the 12 plasma constituents measured, including glucose, were maintained in the control range of levels, but albumin, inorganic phosphate and urea nitrogen levels were altered after hypophysectomy or GH replacement.
Three to four weeks after hypophysectomy, total glucose oxidation and glucose utilization by the islets were slightly depressed. Hypophysectomy appeared to slow down glucose 6-phosphate utilization in the islets. However, the functional capacity of the glucose phosphorylating, glucose-6-phosphate and 6-phosphogluconate dehydrogenase activities were not changed. Short-term GH replacement caused improvements in these islet functions. Experimental evidence accumulated by 1968 indicated that development of diabetes in animals treated with growth hormone (GH) could depend on the failure of the pancreatic islet cells to supply adequate quantities of insulin in the presence of greatly increased peri¬ pheral insulin antagonism. In man, GH appeared to enhance the development of diabetes in patients with a predisposition to diabetes, i.e. a pancreatic disorder probably of here¬ ditary origin .
In young adult rats, hypophysectomy was associated with weight loss and hypoglycaemia (Malaisse, Malaisse-Lagae, King & Wright, 1968; Schatz, Abdel Rahman, Hinz, Fehm, Nierle & Pfeiffer, 1973a; Schatz, Katsilambros, Hinz, Voigt, Nierle & Pfeiffer, 1973b) , and reduced immunoreactive insulin release from the isolated pancreatic islets (Martin & Gagliardino, 1967; Schatz et al. 1973 , b) or pancreas pieces (Malaisse et al. 1968 ) in response to glucose. These changes were partially reversed by short-term GH replacement.
The differences in the insulin secretory capacity of the islets of hypophysectomized rats before and after GH replacement and of the control rats were attributed to the corre¬ sponding differences in the body weights of these rats (Schatz et al. 1973 a, b) .
Inhibition of the glucose-stimulated insulin release from isolated pancreatic tissue has been associated with the inhibition of islet glucose metabolism (Jarrett & Keen, 1968; Ashcroft, Hedeskov & Rändle, 1970; Hellman, 1970; Hellman, Idahl, Lernmark, Sehlin & Täljedal, 1973) . Insulin release has been considered to be con¬ trolled by changes in the turnover of an intermediate, a co-factor or a product of glucose metabolism (Matschinsky & Ellerman, 1968; Montague & Taylor, 1969; Lambert, Kanazawa, Burr, Orci & Renold, 1971 ; Ammon, Patel & Steinke, 1973; Ashcroft, Weerasinghe & Rändle, 1973) , or to changes in the intracellular levels of glucose (Matschinsky, Ellerman, Krzanowski, Kotlerbrajtburg, Landgraf & Fertel, 1971) . The aim of the present study was, therefore, to investigate the effect of hypophysectomy and short-term GH replacement on insulin release from and the glucose metabolism of isolated rat islets of Langerhans incubated with glucose and other stimulants. The changes in food consumption, in body, pancreas and adrenal gland weights, and in the concentrations of some constituents of blood plasma were also measured before and after GH replacement. The control rats were pair-fed with their hypophysectomized litter-mates and the DNA content or the dry weight of the islet samples was used as a basis of reference for the esti¬ mated islet cell functions (Parman, 1975 (Parman, 1975) ; for microanalytical estimation of islet metabolites the 339 nm monochromator and the Locarte LF/5 with maximal transmission at 475 nm were the primary and seconda filters, respectively.
Rats
Male albino Sprague-Dawley rats of 230-280 g body weight were purchased from CarworthEurope Laboratory Animals Centre, Huntingdon. The rats were ordered from the same litter, and were paired by similarity of body weight within 5 g on the day of hypophysec tomy. One member of each pair was hypophysectomized by the pharyngeal method. The rats were killed by decapitation 3 to 4 weeks after hypophysectomy, the time generally taken for all metabolic activities associated with an intact hypophysis to regress (Riddick, Reisler & Kipnis, 1962 Trinder (1969) .
Isolation of islets Islets were isolated by a collagenase method (Parman, 1975) based on that of Howell & Taylor (1966) . The standard procedure for handling the isolated islets was to pre-incubate the islets in 3-3 mM-glucose for 30 min, wash twice with buffer at 38°C and re-incubate in the experimental media.
Incubation and sampling of media for insulin immunoassay Incubation media were prepared as iso-osmolar solutions in a bicarbonate buffered salts medium (Gey & Gey, 1936) , gassed with a 95 % 02 and 5 % C02 mixture at 0°C and then supplemented with 2 mg crystalline bovine serum albumin/ml. The media were then warmed to 38°C immediately before use and transferred by microsyringe into incubation vials of 2 ml capacity. Islets were transferred in a fine stainless steel wire loop ; the vials were sealed with 'suba seal' (no. 5) soft rubber stoppers through which samples were withdrawn by microsyringe without altering the internal gas and temperature equilibrium. At the end of incubations, islets were recounted, transferred into extraction tubes (Pyrex, 2-3 mm 25 mm internal dimensions), and dropped into liquid nitrogen after aspirating all liquid.
For accurate estimation of the insulin released during the first 20 min after incubation began, 30 medium-to-large sized islets were suspended in 300 µ medium and a zero sample of 20-30 µ\ was withdrawn. Five, 10, 15 and 20 min after incubation 10, 10, 15 and 15 µ\ samples respectively were withdrawn. Incubation volumes were then increased to 500-800 µ by gently injecting more medium at 38 CC. Thirty minutes, 1, 2 and 3 h after starting the incubation, 10 or 15 µ samples were removed. The object of these volume adjustments was to sample not less than 8-10/¿u. of immunoreactive insulin which when reconstituted to 0-4 ml in the immunoassay buffer should be equivalent to 20-25 µ . of the standard rat insulin. If the zero-time insulin level of a sample was higher than 8-10 µ . equivalent of standard rat insulin/ml, islets were suspected to be leaky and the relevant series of samples was discarded.
Insulin immunoassay
The assay procedure outlined in the kit employed was modified in two respects to improve the sensitivity of the assays at the low (1963) .
Glycogen synthesis The method of estimating glycogen synthesis was based on the procedure outlined by Ashcroft et al. (1972) , and the glycogen estimation method of van Handel (1965 (Ashcroft & Rändle, 1968) and the 3H20 content was estimated (Ashcroft et al. 1972 ). Islets were collected, freeze-dried and weighed, and the glycogen was extracted, dialysed and the incorporated radioactivity determined (Ashcroft et al. 1972 ). The recovery of 10/¿g rabbit liver glycogen extracted with or without freeze-dried islets was 91-93 % as estimated by the anthrone method of Van Handel (1965) .
Estimation of islet DNA content The method employed was based on that of Rissane & Robins (1958) and has been de¬ scribed elsewhere (Parman, 1975) .
Extraction of islet RNA The DNA extraction method of Rissane & Robins (1958) was modified for quantitative isolation and separation of DNA and RNA after the RNA extraction methods described by Fleck & Munro (1962) , Munro & Fleck (1966) and Blobel & Potter (1968) . The DNA and RNA of freeze-dried islet samples were precipitated with 0-25 M-perchloric acid at 0°C , the precipitate was dissolved at 38°C in an aqueous solution of 32 µg crystalline RNA, 0-875 M-KOH was added to adjust the volume and KOH concentration to 0-3 m and the RNA was broken down for 75 min at 38°C. The tubes were then cooled to 0°C, acidified to give a final perchloric acid concentration of 0-25 m to reprecipitate DNA, which was then extracted with the original method (Parman, 1975) . The acid supernatant con¬ taining the RNA and the two successive 0-25 M-perchloric acid washings of the DNA precipitate were directly mixed with 0-4 ml hyamine and counted in 12 ml toluene scintil¬ lator after temperature equilibration at 8°C.
Estimation of islet metabolites
The ATP, glucose, glucose 6-phosphate, 6-phosphogluconate and fructose 1,6-diphosphate contents of the isolated islets were estimated by the microanalytical methods described by Matschinsky, Passonneau & Lowry (1968a) and Matschinsky, Rutherford & Ellerman (19686) . Four to twenty micrograms of freeze-dried islet samples were used for these assays designed to estimate 200 pmol or more of glucose or ATP by direct fluorometry in 100 µ reaction volume, and 0-05-0-4 pmol glucose 6-phosphate, 6-phosphogluconate or fructose 1,6-diphosphate by enzymic cycling methods in 5-10 /*1 reaction volumes. Islet ATP was extracted with 1-0 µ\ 0-1 M-NaOH at 60°C for 15 min, and the other metabolites were extracted with 1-2 µ 0-02 M-HC1 at 60°C for 30 min, aliquots of the extracts were used for the assay of each metabolite.
Assays of islet enzymes
The glucose phosphorylating and the glucose-6-phosphate 6-phosphogluconate dehydro¬ genase activities were estimated by the method of Thalmann, Matschinsky & Thalmann (1970) In winter, the body weight of pair-fed control rats decreased to about 90 % and 85-5 % of their initial weight by the end of the first and second weeks after hypophysectomy of their litter-mates. Thereafter, weight loss was gradual in hypophysectomized (Hypo) and control rats, with the body weights of the hypophysectomized rats reaching 71-73 % of the initial weight by day 21. After 3 or 5 days of GH replacement, body weights increased to 83 or 87 % of the initial weight, respectively; the greatest increase occurred on the 1st day of GH treatment, with only slight increases evident thereafter. In summer, weight loss and gain by the control and Hypo rats were less marked than in winter, but the general pattern was similar.
After hypophysectomy, pancreatic and adrenal gland weights fell. Short-term GH replacement did not influence this decrease in the pancreatic weight, as was demonstrated by Malaisse et al. (1968) . A slight increase in the adrenal gland weight was recorded (Table 1) after GH replacement.
Food intake
The overall range of food intake by the Hypo rats was 8-29 g of the M.R.C, cube diet 41B/rat/day. The range per experimental group was 6-7 g/rat/day and the daily fluctuations per rat were 1-3 g. Food consumption did not increase during GH replacement. 
Effect of hypophysectomy on insulin release
Glucose-stimulated insulin release (i) Change in insulin release with change of glucose concentration in the incubation medium was estimated in three experiments ( -C) using rats with comparable ranges of body weights (Table 3 ). Three to four weeks after hypophysectomy, the depression in insulin release was not marked in 5-6 mM-glucose but in 11-1-23-0 mM-glucose the response ranged from 68-59 % (Expt A) to 66-59 % (Expt B) of the corresponding control levels, and 3 days of replacement increased the response to 80-70 % (Expt A) or 88-76 % (Expt B) of the control values, respectively. Expt (C) was carried out with the two groups of ten rats initially weighing 250 ± 10 (mean ± s.e.) g or 275 ± 10 g respectively; five rats in each group were hypophysectomized. The weight relationship did not alter during the 22-26 days after hypophysectomy. The lighter Hypo rats (188 ± 3 g) were given 5 days of GH replacement therapy such that the weight range increased to the level of the heavier untreated Hypo group (213 + 5 g). As previously observed in Expts (A) and (B) insulin release in 4-2 or 5-6 mM-glucose was not greatly altered after hypophysectomy. In medium containing 8-3-23-0 mM-glucose it was 78-62 % of the control and increased to 93-75-5 % of the control, after the 5 days of GH replacement.
These results suggest that the improvement in the glucose-stimulated insulin release after GH replacement was not due to small increases in the body weights of the rats over those of the untreated Hypo rats, since the insulin secretory capacity of the islets increased despite the identical range of weights of the treated and untreated Hypo rats. Also, the increase in the glucose-stimulated insulin release was not changed by alterations in the duration of the bovine GH replacement treatment. (ii) Change in insulin release with period of incubation in 4-2 or 16-7 mM-glucose, and the effect of raising the glucose concentration to 40-0 mM after pre-incubation with 16-7 mMglucose for 2 h was measured as described in the legend to Fig. 1 . In medium containing 4-2 mM-glucose, insulin release from islets of Hypo, Hypo + GH-treated and control rats became apparent after 5 min of incubation. During the 5-15 min after starting the incu¬ bations, the ratios between insulin release in 16-7 mM-glucose and in 4-2 mM-glucose by islets from Hypo and Hypo + GH-treated rats were similar (1-88±0-16 and 1-92 + 0-16, respectively, = 6, mean ±s.d.) and were consistently below the corresponding ratios for the control islets (2·39±0·19, = 12). These ratios for the islets of Hypo + GH-treated rats at 20 min and 180 min (2-12 + 0-20 and 3-16 ±0-32, = 6) exceeded those for the Hypo rat islets (2-03 ±0-21 and 2-41 ±0-21, figure) after starting the incubations to estimate the total insulin content of these media. The remaining single or duplicate incubations in 16-7 mMglucose were also sampled similarly between 0 and 60 min after incubation, but the 120 min sample was withdrawn 5-10 min after injecting a calculated amount of glucose in a volume less than 1 % of the total incubation volume to raise the glucose concentration from 16-7 to 400 mM. These 'modified' media were then sampled at 125, 130 (Table 5 ). The 'enhancing' effect of 1-0 mM-theophylline was about twice that of dibutyryl cyclic AMP or glucagon. These findings show that the enhancement of insulin release by these agents depends on the extent of glucose stimulation of insulin release. Effect of hypophysectomy or bovine GH replacement on islet glucose oxidation or utilization Effect of changing glucose concentration in the incubation medium on total glucose oxidation Islets were incubated for 2 h with 3-3 /iCi D-[U-14C]glucose/ml in 100 µ\ 4-2, 5-6, 8-3, 11-1 or 16-7 mM-glucose, and the 14C02 produced was estimated. After the incubations the islets were collected, freeze-dried and weighed. The results are expressed as nmol glucose converted to C02//ig islet DNA, using the relationship of islet dry weight to islet DNA content (Parman, 1975 (Kirby, 1956) , which partly determine the acid precipitability of RNA (Martinez-Segovia, Sokol, Graves & Ackermann, 1965) . Islet incubation with high concentrations of glucose is known to accumulate glycogen (Hellman & Idahl, 1970) , which would be expected to contaminate the RNA extracted by the method des¬ cribed earlier. Therefore, concomitant incorporation of [5-3H] glucose into islet glycogen and its conversion to 3H20 were estimated to establish whether islet glycogen synthesis constituted a significant percentage of total glucose utilization and whether it was altered after hypophysectomy, since these would indicate if the contribution of the glycogen con¬ taminant to the extracted labelled islet RNA would change under these conditions. Hypophysectomy with or without GH replacement did not significantly alter incorpora¬ tion of exogenous glucose into islet glycogen. When the glucose concentration in the incubation medium was raised from 4-2 to 16-7 mM, glycogen synthesis increased 2-85, 2-9 or 3-2-fold in islets from Hypo, Hypo + GH-treated or control rats respectively. During the incubations in 4-2 and 16-7 mM-glucose, glycogen synthesis constituted 6-7-6-8 % of the estimated glucose utilization at both glucose concentrations.
Incorporation of C6 of glucose into islet RNA was about 110 % and 80 % of its oxidation to C02 in 4-2 and 16-7 mM-glucose, respectively. In islets from Hypo rats incubated with 16-7 mM-glucose, the change in glucose incorporation into islet RNA was, like its incor¬ poration into islet glycogen, not significant. The depression of glucose incorporation did not exceed 10 % of the control value. It is concluded that hypophysectomy and GH re¬ placement do not greatly alter glucose incorporation into islet RNA.
Effect of hypophysectomy and subsequent short-term bovine GH replacement on the glucose, glucose 6-phosphate, 6-phosphogluconate, fructose 1,6-diphosphate and ATP content of the is¬ lets in relation to the concomitant release of insulin estimated after various types of incubations (Table 6) The ratios of the glucose content of the islets of Hypo, Hypo + GH-treated or control rats to glucose concentrations in the incubation medium of 16-7 or 4-2 mM were 3-35 10~6 and 3-46 IO-6 respectively. If rat islets are assumed to consist of 75-80 % by weight of water as estimated for mouse islets (Matschinsky & Ellerman, 1968; , then the ratio of islet glucose content to the incubatory glucose should be close to unity. Glucose 6-phosphate, 6-phosphogluconate and fructose 1,6-diphosphate levels of all three types of islets were similar at the same glucose concentration, and increased by about 2-4 (Hypo), 1-7 (Hypo + GH) and 3-7-fold (control), when the glucose concentration in the medium was raised from 4-2 to 16-7 mM. In 16-7 mM-glucose, the glucose 6-phosphate and 6-phosphogluconate levels in islets from Hypo and Hypo + GH-treated rats were slightly lower than the corresponding control levels. However, it was not possible to correlate the significant changes in insulin release in the presence of 16-7 mM-glucose with the virtual lack of change in the steady-state levels of these metabolites before and after GH replace¬ ment.
After 1 h incubation in the presence of 6-0 mM-citrate alone the glucose 6-phosphate and fructose 1,6-diphosphate levels were lower and the 6-phosphogluconate levels were slightly higher than the corresponding levels estimated in islets incubated with 4-2 mMglucose. In the presence of 1 -0 mM-tolbutamide the glucose 6-phosphate levels of islets from Hypo and Hypo + GH-treated rats were lower than, and the 6-phosphogluconate and fructose 1,6-diphosphate levels were similar to, the corresponding levels when the islets were maintained in 4-2 mM-glucose only. After incubation with citrate or tolbutamide alone, glucose 6-phosphate levels in islets from Hypo and Hypo + GH-treated rats were higher than those of the control rats, the difference being greater between the Hypo and control rats, and more pronounced in the presence of citrate. Insulin release after 60 min but not 20 min of incubation was distinctly higher in the presence of citrate than with tolbutamide, but these levels at 60 min were higher with citrate or tolbutamide than with 4-2 mM-glucose. Table 6 . The steady-state levels of ATP, glucose, glucose 6-phosphate (G-6-P), 6-phospho¬ gluconate (6-P-G), fructose 1,6-diphosphate (F-l,6-P2) Nineteen hypophysectomized (Hypo), 18 Hypo + GH rats and their respective pair-fed controls were used. Batches of 22-31 islets from each rat were incubated singly or in duplicate in 4-2 mM (series 1) or 16-7 mM (series 2) glucose, 60mM-citrate (series 3) and 1-0 mM-tolbutamide (series 4) for 60 min. Samples of media were taken for total insulin determinations after incubation for 20 and 60 min. The islets were then collected, freeze-dried, weighed and extracted for the estimation of the metabolite content. In the incubations with glucose (incubations 1 and 2) none of the differences of Hypo or Hypo + GH and the respective control values are statistically significant.
The level of significance for the differences in the G-6-P content of islets from Hypo and Hypo + GHtreated rats and of the islets from their respective controls in incubations 3 and 4 is < 0-0005.
Effect of hypophysectomy and bovine GH replacement on the functional capacity of glucose phosphorylating, glucose-6-phosphate dehydrogenase and 6-phosphogluconate hydrogenase activities in the isolated islets
The activities of hexokinase, glucose-6-phosphate and 6-phosphogluconate dehydrogenases were estimated in the freeze-dried and weighed islets previously incubated with 4-2 mMglucose. The (1973 ) reported distinct hypoglycaemia after hypophysectomy of rats, which returned to control levels after GH replacement. The higher plasma glucose levels of their control rats may be due to feeding ad libitum with consequent normal rates of growth. The difference between our results and the finding by these workers may be explained by the increased food intake of their rats (Bassett & Wallace, 1966) or the use of a different type of food or GH preparation.
The rise in plasma inorganic phosphate concentration (Table 2 ) may be associated with increased bone résorption, while the fall in urea nitrogen is consistent with increased nitrogen retention, which could only occur in the presence of an adequate insulinotrophic response of the pancreatic islets (Scow, 1957; Prader, Zachmann, Poley & Illig, 1968) , which has been interpreted as 'a dynamic response' of the islets to the enhanced peripheral insulin antagonism. Work with hypophysectomized and/or adrenalectomized animals has indicated that glucocorticoids, together with GH, are necessary for the development of peripheral insulin antagonism by alteration of muscle and adipose tissue metabolism (Park, Brown, Cornblath, Daughaday & Krahl, 1952; Scow, Chernick & Guarco, 1959; Scow & Chernick, 1960; Marshall & Engel, 1960; Morgan, Regen, Henderson, Sawyer & Park, 1961; Fain, 1962; Riddick et al. 1962; Fain, Scow & Chernick, 1963; Fain, Kovacev &Scow, 1965; Goodman, 1965a, è; Hjalmarson & Ahren, 1967a, b; Hjalmarson, 1968a-d) . The increase in the adrenal weights of Hypo rats after GH replacement observed in the present study confirmed earlier findings in rats (Cater & Stack-Dunne, 1955) and rabbits (Ogilvie & Mclean, 1960) , and may be relevant in this context. An increase in the urinary products of glucocorticoid metabolism during GH treatment of hypopituitary patients has also been reported (Escamilla, Hutchings, Deamer, Li & Forsham, 1961 ; Prader et al. 1968 ).
Three to four weeks after hypophysectomy, insulin release from isolated islets incubated with 16-7 mM-glucose was reduced to 60 % of that of the control islets. Improvement to 80 % of the control values occurred after GH replacement, which also dramatically increased the rapid insulin response of islets from Hypo + GH-treated rats to stimulation with high concentrations of glucose after, but not before, long-term pre-incubation with 16-7 mM-glucose. It appears that the low rates of insulin release from the islets of Hypo + GHtreated rats incubated with glucose immediately after isolation and resting may be due to the diminished level of a critical factor maintained by glucose under hormonal (GH) control.
The effect of GH replacement on the insulin release estimated 20 min after starting the incubations of islets from Hypo + GH-treated rats, however, could be detected without pre-incubation in high concentrations of glucose, suggesting the possibility of there being two sequentially separated mechanisms influencing insulin release.
Enhancement of insulin release by dibutyryl cyclic AMP, glucagon or theophylline was proportional to the stimulatory effect of glucose alone ( & Malaisse, 1973) . In contrast, the inhibitory effect of starvation on glucose-stimulated insulin release from isolated mouse islets could be reversed by exogenous cyclic AMP (Capito & Hedeskov, 1974) .
After hypophysectomy there was an approximately 10 % decrease in total glucose oxidation in the presence of high glucose concentrations. As briefly mentioned in the Introduction, insulin release appears to be dependent on islet glucose metabolism. For example, GH, which inhibited insulin release 15-20 min after incubation of the islets with glucose, also completely abolished glucose oxidation by the islets (A. U. Parman, un¬ published observations). The differences in the insulin secretory capacity of the islets from Hypo and control rats became more apparent at glucose concentrations higher than 8-3 mM. The fall in glucose oxidation or utilization was also detected above the 8-3 mM-glucose concentration. The extent of insulin release at the end of 60-min incubations with xylitol, «-butyrate, citrate, leucine, arginine or tolbutamide was similar to or less than the insulin levels attained with 8-3 mM-glucose alone, and the effect of hypophysectomy and GH replacement on this insulin release was not clearly defined (Tables 3 and 4) . Earlier work on changes in the course of insulin release from isolated islets of normal rats incubated with xylitol, leucine or tolbutamide in the presence of adrenaline, GH, iodoacetate or 2-deoxy-D-glucose suggested that the effects of these stimulants on the insulin-releasing mechanism may depend on different modes of stimulation, possibly at the level of the islet-celi membrane, since the glucose-stimulated insulin release was more rapidly and strongly inhibited (A. Ü. Parman, unpublished observations). There is other evidence to suggest that glucose and tolbutamide may associate with the islet cell membrane in different ways (Basabe, Lopez, Viktora & Wolff, 1971; Maier & Pfeiffer, 1972; Malaisse, Mahy, Brisson & Malaisse-Lagae, 1972; Krause, Puchinger & Wacker, 1973; Hedeskov & Capito, 1975) . In early stages of diabetes in man the first phase of insulin release in vivo is dimin¬ ished or delayed after i.v. administration of glucose , but not after i.v. secretin (Deckert, 1968) or i.v. tolbutamide injection (Goldsmith, Yalow & Berson, 1969) . Therefore, hypophysectomy may influence islet cell membrane properties, and the sensitivity to glucose and the other stimulants tested may not have been altered equally.
The slightly lower glucose 6-phosphate and 6-phosphogluconate levels in the islets from Hypo and Hypo + GH-treated rats after incubation with 16-7 mM-glucose could reflect a fall in the turnover of these intermediates of glucose metabolism after near maximal stimulation of the islets with glucose. In the presence of 4-2 mM-glucose no differences in these levels could be detected in islets from all three treatments. However, in the absence of glucose in the medium but the presence of citrate or tolbutamide the glucose 6-phosphate levels in the islets from Hypo and Hypo + GH-treated rats were consistently higher than those of the control islets (Table 6 ). These islets were pre-incubated with 3-3 mM-glucose before incubation with citrate or tolbutamide. Therefore, the steady-state glucose 6-phos¬ phate levels at the beginning of these incubations should have been only slightly less than the levels in the islets incubated with 4-2 mM-glucose (see (Hellman & Idahl, 1970) . These results indicated that in the presence of glucose the estimated levels of islet metabolites do not give information about the turnover rates. The inability to detect a corresponding drop in the basal rates of glucose oxidation or utilization in the presence of 4-2 mM-glucose, as also in the oxidation of the C1 or C6 of the glucose molecule at low or high concentrations of glucose, may be due to the use of glucose preparations of insufficiently high specific radioactivity to indicate marginal differences in these oxidation rates.
It is concluded that hypophysectomy depresses and GH replacement improves the sen¬ sitivity to glucose of the insulin-releasing mechanisms possibly by altering the glucose receptor mechanism and the coupling of glucose metabolism to the secretory mechanisms. The changes in islet glucose metabolism may be a direct effect of these hormonal treat¬ ments or arise from a feedback by the secretory mechanisms of which the energy require¬ ments and responsiveness to a 'signal metabolite' have been modified.
